The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | Assessing the optimal CT screening interval for those at a lower risk of lung cancer
Kevin ten Haaf, PhD, Erasmus University Medical Center, Rotterdam, Netherlands, discusses a comparative modeling study from the Cancer Intervention and Surveillance Modeling Network (CISNET) evaluating lung cancer screening strategies. The study assesses whether adapting screening intervals (annual vs. biennial) based on age, sex, and smoking exposure can maintain the benefits of annual screening while reducing the number of CT scans. Results indicate that biennial screening at ages 50-60 effectively preserves most benefits, especially in individuals with lower smoking exposure, and is cost-effective for those with higher smoking history. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
